The USPTO has ruled that AI cannot be named as a patent inventor, aligning with recent decisions by UKIPO and EPO. The Indian Patent Office has extended the SIPP Scheme, while CSIR allows deferred payments for COVID-19 related IP. Key updates also include Gilead’s global access strategy for Remdesivir and new developments from IPOS Singapore and USTR.
Read more about AI cannot be an inventor rules USPTO, IPO extends SIPP Scheme and other patent newsTag: AI inventor
AI named as inventor in patent, AI to be inducted in Patent Office’s operations, 3M versus Saint-Gobain and more
The bulletin examines Indian patent data, the induction of AI in patent processes, and global legal updates including AI as an inventor. It includes notable cases and legislative changes, providing a structured legal overview. Insights are curated by the patent team at BananaIP Counsels.
Read more about AI named as inventor in patent, AI to be inducted in Patent Office’s operations, 3M versus Saint-Gobain and more